Abstract
Joanna Moncrieff looks at the lack of long-term evidence for antipsychotic medication and considers what is needed to ensure we have the knowledge to maximize benefits and minimize harms.
MeSH terms
-
Antipsychotic Agents / administration & dosage*
-
Antipsychotic Agents / adverse effects
-
Disease Progression
-
Drug Administration Schedule
-
Humans
-
Maintenance Chemotherapy / methods*
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Schizophrenia / drug therapy*
Grants and funding
No funding was received for this work.